| Literature DB >> 30646209 |
Denise Shuk Ting Cheung1, Wen Deng1, Sai-Wah Tsao2, Rainbow Tin Hung Ho3,4, Cecilia Lai Wan Chan4, Daniel Yee Tak Fong1, Pui Hing Chau1, Athena Wai Lin Hong1, Helina Yin King Yuk Fung5, Joyce Lai Chong Ma6, Agnes F Y Tiwari7.
Abstract
Importance: Qigong is a mind-body exercise that may be an effective self-care intervention for improving the well-being of women survivors of intimate partner violence. Objective: To test whether a qigong intervention would increase telomerase activity and improve mental health in Chinese women who survived intimate partner violence. Design, Setting, and Participants: A single-blind randomized clinical trial among Chinese women (N = 271) who survived intimate partner violence in the past 2 years recruited from a community center in Hong Kong, China. The trial was conducted from March 12, 2014, to May 26, 2016. Data analysis was by intention to treat and performed from June 7 to August 24, 2018. Interventions: Randomization (1:1) to a 22-week qigong intervention (n = 136) that included 22 weeks of Baduanjin qigong group training (1-6 weeks: 2-hour sessions biweekly; 7-22 weeks: 1-hour follow-up sessions weekly) and self-practice (30 minutes per day for 22 weeks) or to a wait-list control group (n = 135) that received optional monthly health education sessions unrelated to qigong after 6 weeks (posttraining period) and qigong training after 22 weeks (postintervention period). Main Outcomes and Measures: The primary outcome was telomerase activity in peripheral blood mononuclear cells. The secondary outcomes included levels of proinflammatory cytokines (tumor necrosis factor and interleukin 6) in peripheral blood plasma, depressive symptoms (Beck Depression Inventory II score; score range, 0-63; higher scores represent more severe depressive symptoms), perceived stress (Perceived Stress Scale; score range, 0-40; higher scores represent higher stress), and perceived coping (Perceived Coping Scale; score range, 0-13; higher scores represent use of more coping strategies).Entities:
Mesh:
Substances:
Year: 2019 PMID: 30646209 PMCID: PMC6484539 DOI: 10.1001/jamanetworkopen.2018.6967
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure. Flow of Participants Through the Study
Baseline Sociodemographic Characteristics Among Chinese Women Survivors of Intimate Partner Violence Receiving a Qigong Training Intervention vs Wait-List Control
| Characteristic | Intervention Group, No. (%) (n = 136) | Wait-List Control Group, No. (%) (n = 135) |
|---|---|---|
| Age, mean (SD), y | ||
| Women | 42.0 (8.7) | 41.5 (9.3) |
| Intimate partner | 47.5 (9.5) | 47.2 (9.6) |
| Educational level | ||
| ≤6 y | 25 (19) | 15 (11) |
| 7-13 y | 101 (75) | 111 (83) |
| Tertiary | 9 (7) | 8 (6) |
| Place of birth | ||
| Hong Kong | 27 (20) | 29 (21) |
| Mainland China | 109 (80) | 106 (79) |
| Duration of marriage, mean (SD), y | 21.3 (23.4) | 20.2 (21.2) |
| Marital status | ||
| Married or cohabiting | 124 (91) | 128 (95) |
| Single | 4 (3) | 2 (1) |
| Divorced | 8 (6) | 5 (4) |
| ≤1 Child | 44 (32) | 50 (37) |
| Chronic illness | ||
| Woman | 22 (16) | 22 (16) |
| Intimate partner | 16 (12) | 18 (13) |
| Employed | ||
| Woman | 34 (25) | 21 (16) |
| Intimate partner | 111 (82) | 115 (85) |
| Experiencing financial hardship | 93 (69) | 93 (69) |
| Exercises regularly | 51 (38) | 44 (33) |
| Smokes daily | 6 (4) | 4 (3) |
| Drinks alcohol | 8 (6) | 7 (5) |
Financial hardship was determined by self-reported financial hardship of the respondent as elicited from the demographic questionnaire.
Exercising regularly means having a regular exercise routine such as once per week. This information was self-reported.
Outcomes at Baseline, Posttraining Assessment (After Week 6), and Postintervention Assessment (After Week 22) Among Chinese Women Survivors of Intimate Partner Violence Receiving a Qigong Training Intervention vs Wait-List Control
| Intervention Group (n = 136) | Wait-List Control (n = 135) | Between-Group Difference | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Each Time Point | Change From Baseline | ||||||||||
| Mean (95% CI) | Within-Group Change From Baseline (95% CI) | Mean (95% CI) | Within-Group Change From Baseline (95% CI) | Mean (95% CI) | Mean (95% CI) | ||||||
| Telomerase activity, U | |||||||||||
| Baseline | 5.05 (4.94 to 5.16) | NA | NA | 5.17 (5.06 to 5.28) | NA | NA | 0.12 (−0.28 to 0.03) | .12 | NA | NA | .08 |
| Postintervention assessment | 5.18 (5.05 to 5.31) | 0.13 (0.001 to 0.27) | .05 | 5.14 (5.01 to 5.27) | −0.03 (−0.16 to 0.10) | .64 | 0.04 (−0.14 to 0.22) | .66 | 0.16 (−0.02 to 0.35) | .08 | |
| TNF, pg/mL | |||||||||||
| Baseline | 1.55 (1.23 to 1.88) | NA | NA | 1.31 (0.98 to 1.63) | NA | NA | 0.25 (−0.22 to 0.71) | .29 | NA | NA | .25 |
| Postintervention assessment | 1.35 (1.01 to 1.70) | −0.20 (−0.42 to 0.02) | .08 | 1.29 (0.95 to 1.63) | −0.02 (−0.23 to 0.20) | .88 | 0.07 (−0.41 to 0.54) | .79 | −0.18 (−0.49 to 0.13) | .25 | |
| IL-6, pg/mL | |||||||||||
| Baseline | 0.25 (0.07 to 0.42) | NA | NA | 0.12 (−0.06 to 0.30) | NA | NA | 0.13 (−0.12 to 0.38) | .32 | NA | NA | .27 |
| Postintervention assessment | 0.12 (−0.07 to 0.30) | −0.13 (−0.30 to 0.04) | .13 | 0.13 (−0.06 to 0.31) | 0.005 (−0.16 to 0.17) | .95 | −0.008 (−0.27 to 0.25) | .95 | −0.14 (−0.37 to 0.10) | .27 | |
| PSS score | |||||||||||
| Baseline | 20.65 (19.61 to 21.68) | NA | NA | 20.18 (19.14 to 21.22) | NA | NA | 0.47 (−1.00 to 1.94) | .53 | NA | NA | .008 |
| Posttraining assessment | 17.76 (16.72 to 18.81) | −2.88 (−4.13 to −1.64) | <.001 | 19.57 (18.55 to 20.60) | −0.61 (−1.83 to 0.62) | .70 | −1.81 (−3.27 to −0.34) | .02 | −2.28 (−3.71 to −0.85) | .002 | |
| Postintervention assessment | 17.59 (16.54 to 18.64) | −3.06 (−4.32 to −1.79) | <.001 | 18.62 (17.60 to 19.65) | −1.55 (−2.79 to −0.31) | .008 | −1.03 (−2.50 to 0.43) | .17 | −1.50 (−2.95 to −0.05) | .04 | |
| BDI-II score | |||||||||||
| Baseline | 18.87 (16.93 to 20.81) | NA | NA | 17.39 (15.44 to 19.33) | NA | NA | 1.48 (−1.26 to 4.23) | .29 | NA | NA | .001 |
| Posttraining assessment | 11.03 (9.12 to 12.94) | −7.84 (−10.11 to −5.57) | <.001 | 14.60 (12.73 to 16.48) | −2.78 (−5.01 to −0.56) | .008 | −3.57 (−6.25 to −0.90) | .009 | −5.06(−7.65 to −2.46) | <.001 | |
| Postintervention assessment | 10.69 (8.92 to 12.47) | −8.17 (−10.36 to −5.99) | <.001 | 12.48 (10.74 to 14.21) | −4.91 (−7.06 to −2.76) | <.001 | −1.78 (−4.26 to 0.70) | .16 | −3.27 (−5.77 to −0.76) | .01 | |
| PCS score | |||||||||||
| Baseline | 6.64 (6.28 to 7.00) | NA | NA | 6.22 (5.86 to 6.58) | NA | NA | 0.42 (−0.09 to 0.93) | .11 | NA | NA | .20 |
| Posttraining assessment | 5.13 (4.70 to 5.57) | −1.51 (−2.10 to −0.91) | <.001 | 5.27 (4.85 to 5.69) | −0.95 (−1.54 to −0.37) | <.001 | −0.14 (−0.74 to 0.47) | .66 | −0.56 (−1.24 to 0.13) | .11 | |
| Postintervention assessment | 5.24 (4.80 to 5.69) | −1.40 (−2.00 to −0.80) | <.001 | 5.33 (4.90 to 5.76) | −0.89 (−1.48 to −0.30) | .001 | −0.09 (−0.71 to 0.53) | .78 | −0.51 (−1.19 to 0.18) | .15 | |
Abbreviations: BDI-II, Beck Depression Inventory II; IL-6, interleukin 6; NA, not applicable; PSS, Perceived Stress Scale; PCS, Perceived Coping scale; TNF, tumor necrosis factor.
Statistics are designated as d in descriptions of the study results.
Percentage relative to a low-telomerase-activity internal control provided by the enzyme-linked immunosorbent assay kit.
Log transformation was performed.
The total score range is 0 to 40, higher scores represent higher stress.
The total score range is 0 to 63, higher scores represent more severe depressive symptoms.
The total score range is 0 to 13, higher scores represent use of more coping strategies.